Rchr
J-GLOBAL ID:201401034168699298
Update date: Oct. 18, 2024
Hashimoto Motomu
Hashimoto Motomu
Affiliation and department:
Job title:
Professor
Research field (2):
Allergies and connective tissue disease
, Immunology
Research theme for competitive and other funds (12):
- 2022 - 2025 Development of anti-MDA5-positive dermatomyositis mouse model with interstitial lung disease
- 2020 - 2023 Microbiotaを起点とする全身性自己免疫疾患の病態解明
- 2019 - 2023 Basic and clinical analysis of anti-drug antibody against therapeutic antibody
- 2019 - 2022 Investigation of risk factors for sarcopenia in patients with rheumatoid arthritis and establishment of a biochemical evaluation method.
- 2018 - 2022 足指力を改善する関節リウマチフットケア介入モデルの開発
- 2018 - 2022 Development of Ultrasonic C-mode imaging system using power Doppler method and clinical application for evatuation of disease activity in rheumatoid arthritis
- 2016 - 2020 Elucidation of the pathogenesis of SLE using SKG mice on C57BL/6 background
- 2015 - 2019 Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis
- 2014 - 2016 Establishment of a lupus animal model by SKG mice on C57BL/6 background
- 2013 - 2016 Pathogenicity of anti-U1RNP antibodies in neuropsychiatric systemic lupus erythematous
- 2011 - 2012 Role of GM-CSF secreting CD4 T cells in rheumatoid arthritis and its animal model
- 関節リウマチ患者のサルコペニア改善と分子標的薬の寛解休薬をめざした運動療法の治療ストラテジー開発
Show all
Papers (355):
-
Takeshi Iwasaki, Ryu Watanabe, Hiromu Ito, Takayuki Fujii, Koichiro Ohmura, Hiroyuki Yoshitomi, Koichi Murata, Kosaku Murakami, Akira Onishi, Masao Tanaka, et al. Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritis. Arthritis Research and Therapy. 2024. 26. 1
-
Takayuki Fujii, Koichi Murata, Hideo Onizawa, Akira Onishi, Masao Tanaka, Kosaku Murakami, Kohei Nishitani, Moritoshi Furu, Ryu Watanabe, Motomu Hashimoto, et al. Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort. Arthritis Research and Therapy. 2024. 26. 1
-
Hiroshi Doi, Koichiro Ohmura, Motomu Hashimoto, Kentaro Ueno, Yudai Takase, Ryuta Inaba, Tomohiro Kozuki, Takeshi Iwasaki, Masashi Taniguchi, Yuya Tabuchi, et al. Factors affecting discrepancies in disease activity evaluation between patients and physicians in systemic lupus erythematosus-The importance of symptoms such as fatigue. Lupus. 2024. 33. 12. 1336-1344
-
Yoichi Nakayama, Akira Onishi, Wataru Yamamoto, Ayaka Yoshikawa, Hideyuki Shiba, Naofumi Yoshida, Yonsu Son, Iku Shirasugi, Toshihisa Maeda, Masao Katsushima, et al. Safety of Janus kinase inhibitors compared to biological DMARDs in patients with rheumatoid arthritis and renal impairment: the ANSWER cohort study. Clinical and Experimental Medicine. 2024. 24. 1
-
Mayu Shiomi, Ryu Watanabe, Shogo Matsuda, Takuya Kotani, Ayana Okazaki, Yuichi Masuda, Tsuneyasu Yoshida, Mikihito Shoji, Ryosuke Tsuge, Keiichiro Kadoba, et al. Factors associated with drug retention of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: A multicentre REVEAL cohort study. Modern rheumatology. 2024
more...
MISC (286):
-
渡部 龍, 橋本 求. 【関節リウマチの治療の現状と問題点】JAK阻害薬 関節リウマチ治療における新たな治療選択肢. リウマチ科. 2022. 67. 4. 407-414
-
山田 真介, 渡部 龍, 橋本 求. 【最新関節リウマチ学(第2版)-寛解・治癒を目指した研究と最新治療-】病因と病態 関節リウマチの病因研究とその進歩 環境要因と生活習慣. 日本臨床. 2022. 80. 増刊4 最新関節リウマチ学. 62-67
-
渡部 龍, 山田 真介, 橋本 求. 【最新関節リウマチ学(第2版)-寛解・治癒を目指した研究と最新治療-】関節リウマチの検査・診断 検査 単純X線検査. 日本臨床. 2022. 80. 増刊4 最新関節リウマチ学. 176-181
-
藤井 貴之, 村田 浩一, 鬼澤 秀夫, 大西 輝, 村上 孝作, 中山 洋一, 稲葉 竜太, 西村 望美, 山本 渉, 前田 悠一, et al. アバタセプト継続率と血球分画の関連 ANSWERコホートを用いた研究. 日本リウマチ学会総会・学術集会プログラム・抄録集. 2022. 66回. 584-584
-
橋本 求. 多職種によるライフステージに応じた関節リウマチ患者支援 多職種協働による高齢期リウマチ患者のトータルケア. 日本リウマチ学会総会・学術集会プログラム・抄録集. 2022. 66回. 199-199
more...
Education (1):
- - 2000 Kyoto University Faculty of Medicine
Professional career (1):
Work history (1):
- 2022/03 - 現在 Osaka Metropolitan University Department of Clinical Immunology Professor
Return to Previous Page